Thomas Gauler

12.5k total citations
152 papers, 3.1k citations indexed

About

Thomas Gauler is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology. According to data from OpenAlex, Thomas Gauler has authored 152 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 80 papers in Oncology and 36 papers in Otorhinolaryngology. Recurrent topics in Thomas Gauler's work include Lung Cancer Treatments and Mutations (66 papers), Head and Neck Cancer Studies (36 papers) and Lung Cancer Diagnosis and Treatment (33 papers). Thomas Gauler is often cited by papers focused on Lung Cancer Treatments and Mutations (66 papers), Head and Neck Cancer Studies (36 papers) and Lung Cancer Diagnosis and Treatment (33 papers). Thomas Gauler collaborates with scholars based in Germany, United States and France. Thomas Gauler's co-authors include Wilfried Eberhardt, Martin Stuschke, Georgios Stamatis, Ulrich Keilholz, Christoph Pöttgen, Martin Schüler, Dirk Theegarten, Lisa Licitra, Viktor Grünwald and Ezra E.W. Cohen and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Thomas Gauler

147 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Gauler Germany	30	1.7k	1.6k	797	560	547	152	3.1k
Ritsuko Komaki United States	32	2.4k 1.4×	1.2k 0.7×	634 0.8×	830 1.5×	638 1.2×	71	3.7k
Jean‐Pascal Machiels Belgium	29	1.1k 0.7×	1.6k 1.0×	806 1.0×	381 0.7×	657 1.2×	137	3.1k
Urs M. Lütolf Switzerland	26	1.4k 0.8×	683 0.4×	715 0.9×	819 1.5×	582 1.1×	50	3.4k
Roger Ove United States	11	1.7k 1.0×	2.0k 1.3×	978 1.2×	492 0.9×	1.1k 2.1×	36	4.1k
Francisco Robert United States	28	1.4k 0.8×	1.8k 1.1×	1.1k 1.4×	290 0.5×	231 0.4×	107	3.2k
J.C. Grecula United States	31	1.0k 0.6×	978 0.6×	430 0.5×	710 1.3×	508 0.9×	159	2.8k
Tomoyuki Hishida Japan	40	2.6k 1.5×	1.7k 1.1×	504 0.6×	666 1.2×	584 1.1×	150	4.1k
Matthew G. Fury United States	38	1.3k 0.8×	2.1k 1.3×	881 1.1×	802 1.4×	1.0k 1.9×	165	4.4k
Kyuichi Kadota Japan	40	3.2k 1.9×	1.9k 1.2×	1.1k 1.4×	773 1.4×	647 1.2×	132	5.1k
Annette Hogg Australia	32	1.1k 0.7×	887 0.6×	591 0.7×	1.2k 2.2×	496 0.9×	50	3.1k

Countries citing papers authored by Thomas Gauler

Since Specialization

Citations

This map shows the geographic impact of Thomas Gauler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Gauler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Gauler more than expected).

Fields of papers citing papers by Thomas Gauler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Gauler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Gauler. The network helps show where Thomas Gauler may publish in the future.

Co-authorship network of co-authors of Thomas Gauler

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Gauler. A scholar is included among the top collaborators of Thomas Gauler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Gauler. Thomas Gauler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guberina, Maja, Christoph Pöttgen, Nika Guberina, et al.. (2024). Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease. Cancers. 16(6). 1174–1174. 3 indexed citations

Guberina, Maja, et al.. (2023). Respiration-controlled radiotherapy in lung cancer: Systematic evaluation of the optimal application practice. Clinical and Translational Radiation Oncology. 40. 100628–100628. 3 indexed citations

Pöttgen, Christoph, Thomas Gauler, Maja Guberina, et al.. (2023). Fractionation versus Adaptation for Compensation of Target Volume Changes during Online Adaptive Radiotherapy for Bladder Cancer: Answers from a Prospective Registry. Cancers. 15(20). 4933–4933. 5 indexed citations

Pöttgen, Christoph, et al.. (2023). Adaptation Time as a Determinant of the Dosimetric Effectiveness of Online Adaptive Radiotherapy for Bladder Cancer. Cancers. 15(23). 5629–5629. 3 indexed citations

Mohr, Christopher, Patricia Johansson, Anja Eckstein, et al.. (2023). MRI-based long-term follow-up of indolent orbital lymphomas after curative radiotherapy: imaging remission criteria and volumetric regression kinetics. Scientific Reports. 13(1). 4792–4792. 1 indexed citations

Bozorgmehr, Farastuk, Fabian Weykamp, Tobias R. Overbeck, et al.. (2023). 1988MO Recruitment discontinuation in TREASURE trial (thoracic radiotherapy with atezolizumab in small cell lung cancer extensive disease) due to unexpected safety data. Annals of Oncology. 34. S1060–S1060. 7 indexed citations

Kansy, Benjamin, Kirsten Bruderek, Yu Si, et al.. (2023). HPV-associated head and neck cancer is characterized by distinct profiles of CD8+ T cells and myeloid-derived suppressor cells. Cancer Immunology Immunotherapy. 72(12). 4367–4383. 4 indexed citations

Bechrakis, Nikolaos E., Anja Eckstein, Henrike Westekemper, et al.. (2022). Long‐term follow‐up and health‐related quality of life among cancer survivors with stage IEA orbital‐type lymphoma after external photon‐beam radiotherapy: Results from a longitudinal study. Hematological Oncology. 40(5). 922–929. 2 indexed citations

Kürten, Cornelius, Thomas Gauler, Martin Stuschke, et al.. (2021). Patterns of cervical lymph node metastasis in supraglottic laryngeal cancer and therapeutic implications of surgical staging of the neck. European Archives of Oto-Rhino-Laryngology. 278(12). 5021–5027. 13 indexed citations

10.

Pöttgen, Christoph, Sied Kebir, Lazaros Lazaridis, et al.. (2021). Dosimetric impact of the positioning variation of tumor treating field electrodes in the PriCoTTF‐phase I/II trial. Journal of Applied Clinical Medical Physics. 22(1). 242–250. 5 indexed citations

11.

Guberina, Nika, Christoph Pöttgen, Martin Schüler, et al.. (2020). Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve. European Journal of Cancer. 138. 156–168. 4 indexed citations

12.

Welslau, Manfred, et al.. (2019). PCN508 A COMPARISON OF PATIENT CHARACTERISTICS TREATED WITH NIVOLUMAB FOR RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) IN GERMANY AND THE USA. Value in Health. 22. S536–S536. 1 indexed citations

13.

Schaarschmidt, Benedikt M., Johannes Grueneisen, Martin Metzenmacher, et al.. (2016). Thoracic staging with 18F-FDG PET/MR in non-small cell lung cancer – does it change therapeutic decisions in comparison to 18F-FDG PET/CT?. European Radiology. 27(2). 681–688. 40 indexed citations

14.

Heusch, Philipp, Christian Buchbender, Jens Köhler, et al.. (2014). Thoracic Staging in Lung Cancer: Prospective Comparison of ¹⁸F-FDG PET/MR Imaging and ¹⁸F-FDG PET/CT. Journal of Nuclear Medicine. 55(3). 373–378. 88 indexed citations

15.

Boeck, Stefan, Jens T. Siveke, Steffen Ormanns, et al.. (2013). P-ERK, P-AKT and p53 as Tissue Biomarkers in Erlotinib-Treated Patients with Advanced Pancreatic Cancer: a Translational Subgroup Analysis From Aio-PK0104. Annals of Oncology. 24. iv12–iv12. 1 indexed citations

16.

Christoph, Daniel C., Andreas-Claudius Hoffmann, Thomas Gauler, et al.. (2012). Detection of Circulating Lung Cancer Cells with Strong Thymidylate Synthase Reactivity in the Peripheral Blood of a Patient with Pulmonary Adenocarcinoma Treated with Pemetrexed. Journal of Thoracic Oncology. 7(4). 766–767. 7 indexed citations

17.

Tinhofer, Ingeborg, Konrad Klinghammer, Wilko Weichert, et al.. (2011). Expression of Amphiregulin and EGFRvIII Affect Outcome of Patients with Squamous Cell Carcinoma of the Head and Neck Receiving Cetuximab–Docetaxel Treatment. Clinical Cancer Research. 17(15). 5197–5204. 76 indexed citations

18.

Pöttgen, Christoph, Wilfried Eberhardt, Thomas Gauler, et al.. (2009). Intensified High-Dose Chemoradiotherapy With Induction Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer—Safety and Toxicity Results Within a Prospective Trial. International Journal of Radiation Oncology*Biology*Physics. 76(3). 809–815. 18 indexed citations

19.

Gauler, Thomas, Benjamin Besse, Jean‐Baptiste Méric, et al.. (2007). C1-01: Phase II open-label study to investigate PTK787/ZK 222584 (PTK/ZK) orally administered as a second-line monotherapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). Journal of Thoracic Oncology. 2(8). S358–S358. 2 indexed citations

20.

Awada, Ahmad, Jean Klášterský, Christian Stoll, et al.. (2003). Abstracts. British Journal of Cancer. 89(S2). S25–S35. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact